Search

Your search keyword '"Delgado, Julio C."' showing total 349 results
Start Over Author "Delgado, Julio C."
349 results on '"Delgado, Julio C."'

2. Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA

Author

Samore, Matthew H., Looney, Adam, Orleans, Brian, Greene, Tom, Seegert, Nathan, Delgado, Julio C., Presson, Angela, Zhang, Chong, Ying, Jian, Zhang, Yue, Shen, Jincheng, Slev, Patricia, Gaulin, Maclean, Yang, Mu-Jeung, Pavia, Andrew T., and Alder, Stephen C.

Subjects
Utah -- Health aspects, Epidemics -- Statistics -- Risk factors -- United States, Health
Abstract

By May 2021, >150 million severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and >3 million deaths from coronavirus disease (COVID-19) had been reported worldwide (1). The real infection count [...]

Published
2021
Full Text
View/download PDF

3. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays

Author

Nandakumar, Vijayalakshmi, Profaizer, Tracie, Lozier, Bucky K., Elgort, Marc G., Larragoite, Erin T., Williams, Elizabeth S.C.P., Solis-Leal, Antonio, Lopez, J. Brandon, Berges, Bradford K., Planelles, Vicente, Rychert, Jenna, Slev, Patricia R., and Delgado, Julio C.

Subjects
Immune system -- Testing, Enzyme-linked immunosorbent assay -- Usage, Immunoglobulin G -- Health aspects, Health
Abstract

* Context.--Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An enzyme-linked immunosorbent assay-based nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration. Objective.--To evaluate the performance characteristics of this assay and compare and correlate it with the commercial assays that detect SARS-CoV-2-specific immunoglobulin G (IgG). Design.--Specimens from SARS-COV-2 infected patients (n = 124), healthy donors obtained prepandemic (n = 100), and patients with non-coronavirus disease 2019 (COVID-19) respiratory infections (n = 92) were analyzed using this assay. Samples with residual volume were also tested on 3 commercial serology platforms (Abbott, Euroimmun, Siemens). Twenty-eight randomly selected specimens from patients with COVID-19 and 10 healthy controls were subjected to a plaque reduction neutralization test. Results.--The cPass assay exhibited 96.1% (95% CI, 94.9%-97.3%) sensitivity (at PCR), 100% (95% CI, 98.0%-100.0%) specificity, and zero cross-reactivity for the presence of non-COVID-19 respiratory infections. When compared with the plaque reduction assay, 97.4% (95% CI, 96.2%-98.5%) qualitative agreement and a positive correlation ([R.sup.2] = 0.76) was observed. Comparison of IgG signals from each of the commercial assays with the nAb results from plaque reduction neutralization test/cPass assays displayed greater than 94.7% qualitative agreement and correlations with [R.sup.2] = 0.43/0.68 (Abbott), [R.sup.2] = 0.57/0.85 (Euroimmun), and [R.sup.2] = 0.39/0.63 (Siemens), respectively. Conclusions.--The combined data support the use of cPass assay for accurate detection of the nAb response. Positive IgG results from commercial assays associated reasonably with nAbs presence and can serve as a substitute. doi: 10.5858/arpa.2021-0213-SA, With the availability of vaccines against the highly pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and as the pressure to reopen the economy increases, the demand for coronavirus disease [...]

Published
2021
Full Text
View/download PDF

12. Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice

Author

Genzen, Jonathan R., Murray, David L., Abel, Gyorgy, Meng, Qing H., Baltaro, Richard J., Rhoads, Daniel D., Delgado, Julio C., Souers, Rhona J., Bashleben, Christine, Keren, David F., and Ansari, Mohammad Q.

Subjects
Immunoglobulins -- Physiological aspects -- Genetic aspects -- Research, Hematologic diseases -- Genetic aspects -- Diagnosis -- Care and treatment -- Research, Health
Abstract

Context.--Serum tests used for the screening and diagnosis of monoclonal gammopathies include serum protein electrophoresis (SPE; agarose gel or capillary zone), immunofixation (IFE) and immunosubtraction capillary electrophoresis, serum free light chains, quantitative immunoglobulins, and heavy/light-chain combinations. Urine protein electrophoresis and urine IFE may also be used to identify Bence-Jones proteinuria. Objective.--To assess current laboratory practice for monoclonal gammopathy testing. Design.--In April 2016, a voluntary questionnaire was distributed to 923 laboratories participating in a protein electrophoresis proficiency testing survey. Results.--Seven hundred seventy-four laboratories from 38 countries and regions completed the questionnaire (83.9% response rate; 774 of 923). The majority of participants (68.6%; 520 of 758) used agarose gel electrophoresis as their SPE method, whereas 31.4% (238 of 758) used capillary zone electrophoresis. The most common test approaches used in screening were SPE with reflex to IFE/immunosubtraction capillary electrophoresis (39.3%; 299 of 760); SPE only (19.1%; 145 of 760); SPE and IFE or immunosubtraction capillary electrophoresis (13.9%; 106 of 760); and SPE with IFE, serum free light chain, and quantitative immunoglobulins (11.8%; 90 of 760). Only 39.8% (305 of 767) of laboratories offered panel testing for ordering convenience. Although SPE was used by most laboratories in diagnosing new cases of myeloma, when laboratories reported the primary test used to follow patients with monoclonal gammopathy, only 55.7% (403 of 724) chose SPE, with the next most common selections being IFE (18.9%; 137 of 724), serum free light chain (11.7%; 85 of 724), and immunosubtraction capillary electrophoresis (2.1%; 15 of 724). Conclusions.--Ordering and testing practices for the screening and diagnosis of monoclonal gammopathy vary widely across laboratories. Improving utilization management and report content, as well as recognition and development of laboratory-directed testing guidelines, may serve to enhance the clinical value of testing. doi: 10.5858/arpa.2017-0128-CP, Monoclonal gammopathies are hematologic disorders characterized by abnormal production of one or more immunoglobulin clones. (1) They range from asymptomatic, benign disorders (such as monoclonal gammopathy of undetermined significance) to [...]

Published
2018
Full Text
View/download PDF

26. Evaluation of Three SARS CoV-2 IgG Antibody Assays and Correlation with Neutralizing Antibodies

Author

Rychert, Jenna, Couturier, Marc Roger, Elgort, Marc, Lozier, Bucky Ken, La’ulu, Sonia, Genzen, Jonathan R, Straseski, Joely A, Delgado, Julio C, and Slev, Patricia R

Subjects
Serology, COVID-19 Testing, SARS-CoV-2, Immunoglobulin G, COVID-19, Humans, Antibodies, Neutralizing, Article
Abstract

Background As serologic assays for SARS-CoV-2 become more widely utilized, it is important to understand their performance characteristics and correlation with neutralizing antibodies. We evaluated three commonly used SARS-CoV-2 IgG assays (Abbott, DiaSorin and EUROIMMUN) for clinical sensitivity, specificity, and correlation with neutralizing antibodies and then compared antibody kinetics during the acute phase of infection. Methods Three panels of samples were tested on every assay. Sensitivity was assessed using a panel of 35 specimens serially collected from 7 RT-PCR-confirmed COVID-19 patients. Specificity was determined using 100 sera samples collected in 2018 from healthy individuals prior to the outbreak. Analytical specificity was determined using a panel of 37 samples from individuals with respiratory illnesses other than COVID-19. Results Clinical sensitivity was 91.43% (95% CI 76.94%-98.20%) for Abbott, and 88.57% (95% CI 73.26%-96.80%) for both DiaSorin and EUROIMMUN. Clinical specificity was 99.00% (95% CI 94.55%-99.97%) for Abbott and DiaSorin and 94.00% (95% CI 87.40%-97.77%) for EUROIMMUN. The IgG assays demonstrated good qualitative agreement (minimum of 94%) and good correlation between the quantitative result for each combination of assays (r2≥0.90). The neutralizing antibody response did not necessarily follow the same temporal kinetics as the IgG response and did not necessarily correlate with IgG values. Conclusion The three IgG antibody assays demonstrated comparable performance characteristics. Importantly, a qualitative positive IgG result obtained with any of the assays was associated with the presence of neutralizing antibodies; however, neutralizing antibody concentrations did not correlate well with signal to cutoff ratios.

Published
2020

29. Evaluation of a Novel Multiplex Platform for Simultaneous Detection of IgG Antibodies Against the 4 Main SARS-CoV-2 Antigens.

Author

Nandakumar, Vijayalakshmi, Profaizer, Tracie, Lozier, Bucky K, Elgort, Marc G, Rychert, Jenna, Slev, Patricia R, and Delgado, Julio C

Subjects
ANTIGENS, IMMUNOGLOBULINS, SARS-CoV-2, POLYMERASE chain reaction, IMMUNOGLOBULIN G, SEROLOGY, RESPIRATORY infections
Abstract

Background: Numerous serology assays are available for detection of SARS-CoV-2 antibodies but are limited in that only 1 or 2 target antigen(s) can be tested at a time. Here, we describe a novel multiplex assay that simultaneously detects and quantifies IgG antibodies to SARS-CoV-2 antigens, spike (S), nucleocapsid (N), receptor-binding domain (RBD), and N-terminal domain (NTD) in a single well. Methods: Sensitivity was determined using samples (n = 124) from confirmed SARS-CoV-2 RT-PCR positive individuals. Prepandemic (n = 100) and non-COVID respiratory infection positive samples (n = 100) were used to evaluate specificity. Samples were analyzed using COVID-19 IgG multiplex serology assay from Meso Scale Discovery (MSD) and using commercial platforms from Abbott, EUROIMMUN, and Siemens. Results: At >14 days post-PCR, MSD assay displayed >98.0% sensitivity [S 100% (95% CI 98.0%–100.0%); N 98.0% (95% CI 97.2%–98.9%); RBD 94.1% (95% CI 92.6%–95.6%); NTD 98.0% (95% CI, 97.2%–98.9%)] and 99% specificity (95% CI 99.3%–99.7%) for antibodies to all 4 antigens. Parallel assessment of antibodies to more than 1 antigen improved the sensitivity to 100% (95% CI 98.0%–100.0%) while maintaining 98% (95% CI 97.6%–98.4%) specificity regardless of the combinations used. When AU/mL concentrations of IgG antibodies from the MSD assay were compared against the corresponding IgG signals acquired from the single target commercial assays, the following correlations were observed: Abbott (vs MSD N, R2 = 0.73), Siemens (vs MSD RBD, R2 = 0.92), and EUROIMMUN (vs MSD S, R2 = 0.82). Conclusion: MSD assay offers an accurate and a comprehensive assessment of SARS-CoV-2 antibodies with higher sensitivity and equivalent specificity compared to the commercial IgG serology assays. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

30. SARS-CoV-2 seroprevalence and detection fraction in Utah urban populations from a probability-based sample

Author

Samore, Matthew H., primary, Looney, Adam, additional, Orleans, Brian, additional, Greene, Tom, additional, Seegert, Nathan, additional, Delgado, Julio C, additional, Presson, Angela, additional, Zhang, Chong, additional, Ying, Jian, additional, Zhang, Yue, additional, Shen, Jincheng, additional, Slev, Patricia, additional, Gaulin, Maclean, additional, Yang, Mu-Jeung, additional, Pavia, Andrew T., additional, and Alder, Stephen C., additional

Published
2020
Full Text
View/download PDF

34. Colaboradores

Author

Abraham, Naif Z., Jr, Aoyagi, Katsumi, Ashihara, Yoshihiro, Asirvatham, Jaya Ruth, Axiotis, Constantine A., Bai, Yu, Balis, Ulysses G.J., Banki, Katalin, Bean, Katie V., Beavis, Kathleen G., Bem, Sylva, Ben-Ezra, Jonathan, Bigdeli, Tim B., Bluth, Martin H., Bobr, Aleh, Bock, Jay L., Borowitz, Michael J., Bowne, Wilbur B., Brandt-Rauf, Paul, Bray, Robert, Bredefeld, Cindy L., Briefel, Gary, Broadhurst, M. Jana, Carty, Robert P., Ceribelli, Angela, Chan, Edward K.L., Charnot-Katsikas, Angella, Cherian, Sindhu, Chiang, Spencer, Clapp, William L., Cooling, Laura Lee, Daniels, Lynsey, Davenport, Robertson D., DeCresce, Robert P., Delgado, Julio C., DeSimone, Robert A., DiGuardo, Margaret A., Paola, Jorge A. Di, Downs, Theresa, Elghetany, M. Tarek, Elkins, Matthew B., Fanous, Ayman, Fritzler, Marvin J., Gebel, Howard M., Goldstein, Eve, Graham, Susan S., Grody, Wayne W., Guber, Helena A., Gupta, Gaurav, Hamilton, Robert G., Harrington, Amanda, Harris, Neil Selwyn, He, Rong, Hilbert, Tim, Hirschhorn, Julie Woolworth, Hogan, Catherine A., Holup, Joseph, Homburger, Henry A., Hsu, Yen-Michael S., Hussain, M. Mahmood, Hutchison, Robert E., Iwen, Peter C., Jain, Shilpa, Jeelani, Roohi, Jennette, J. Charles, Jhang, Jeffrey S., Karcher, Donald S., Kasahara, Yasushi, Kaskovich, Samuel W., Kessler, Craig M., Khalili, Marian, Kidd, Jason, Klein, Michael J., Klemm, Katrin M., Krick, Stefanie, Krummey, Scott, Kumánovics, Attila, Kurec, Anthony, LaDoulis, Charles, Lau, Raymond G., Lázár-Molnár, Eszter, Lee, Grace Ming, Lee, Peng, Li, Jing, Lifshitz, Mark S., Lin, Bo, Mageau, Ronald P., Markell, Mariana, Massey, H. Davis, Mathison, Blaine A., Mathur, Sharad C., McPherson, Richard A., McVoy, Lauren A., Merkel, Kimberly, Meyers, Jacquelyn L., Miller, W. Greg, Mintz, Paul D., Mohi, Golam, Mojica, Angela, Nasr, Michel R., Nikolic, Dejan, Nolte, Frederick S., Oh, Man S., Olano, Juan P., Oprea, Mihaela, Ortel, Thomas L., Ouyang, Zheng, Perle, Mary Ann, Peterson, Roseann E., Pincus, Matthew R., Pinsky, Benjamin A., Plourde, Anna R., Pritt, Bobbi S., Rabinowitz, Simon, Raje, Nikita, Rand, Jacob H., Rao, A. Koneti, Riley, Roger S., Roby, Rhonda K., Rodino, Kyle G., Russell, Yan Xue, Sarode, Ravi, Schandl, Cynthia A., Seydhafkan, Shabnam, Siddiqi, Haseeb A., Songdej, Natthapol, Stein, Constance H., Stempak, Lisa M., Sullivan, H. Clifford, Thompson, George R., III, Vajpayee, Neerja, Viswanatha, David S., von Mühlen, Carlos Alberto, Walker, David H., Wang, Hannah, Weedn, Victor W., Weimer, Eric T., Weinstock, Ruth S., Wengenack, Nancy L., Wiederhold, Nathan P., Winter, William E., Winters, Jeffrey L., Wojewoda, Christina M., Wood, Brent L., Woods, Gail L., Zhang, Wenpeng, and Zhang, Yaxia

Published
2023
Full Text
View/download PDF

35. Textbook Contributors

Author

Aarsand, Aasne K., Abbott, April N., Abraham, Roshini S., Adeli, Khosrow, Alexander, Mariam Priya, Alix-Panabières, Catherine, Alter, David, Anderson, Neil W., Apple, Fred S., Ayling, Ruth M., Babu, Daniel, Badminton, Michael N., Badrick, Tony, Banaei, Niaz, Baudhuin, Linnea M., Bazydlo, Lindsay A.L., Bechtel, Laura K., Benco, John, Bentall, Andrew J., Berg, Marc, Bertholf, Roger L., Best, D. Hunter, Biljak, Vanja Radisic, Block, Darci R., Blum, Lee M., Bodamer, Olaf A., Boh, Benjamin, Bohn, Mary Kathryn, Bossuyt, Patrick M.M., Bossuyt, Xavier, Boyd, James Clark, Braga, Julie A., Buchan, Blake W., Buchbinder, David, Burnett, Leslie, Burnham, Carey-Ann D., Bush, Theresa Ambrose, Bystrom, Cory, Cattaneo, Marco, Caulfield, Adam J., Cervinski, Mark A., Chabot-Richards, Devon S., Chandrakasan, Shanmuganathan, Chen, Derrick J., Chen, Dong, Chiu, Rossa W.K., Clarke, Nigel J., Cole, Timothy J., Cooper, Mark, Crook, Martin, Morena, Maite de la, Delaney, Michael P., Delgado, Julio C., Deresinski, Stanley C., Dietzen, Dennis J., Dinh, Anh P., Doern, Christopher D., Dukić, Lora, Eisenhofer, Graeme, El-Khoury, Joe M., Ellervik, Christina, Florkowski, Christopher M., Fraser, William Duncan, Gandhi, Manish J., Genzen, Jonathan R., George, Tracy I., Glasziou, Paul, Grant, Russell P., Green, Ralph, Hage, David S., Halsall, David John, Hawker, Charles D., Haymond, Shannon, Heaton, Phillip, Higgins, Russell A., Higgins, Victoria, Hilmarsdóttir, Ingibjörg, Hitchcock, Matthew M., Hogan, Catherine A., Holmes, Daniel Thomas, Holstege, Christopher P., Hoofnagle, Andrew N., Horowitz, Gary, Horvath, Andrea R., Howe, John Greg, Humphries, Romney M., Infusino, Ilenia, Jaffe, Allan Stanley, Jones, Graham Ross Dallas, Jones, Patricia M., Julian, Randall K., Jr., Kavsak, Peter A., Kellogg, Mark, Khanolkar, Aaruni, Kidd, Sarah E., Kitchen, Steve, Kreuter, Justin D., Kushnir, Mark M., Lainhart, William D., Lamb, Edmund J., Landers, James P., Langman, Loralie J., Laterza, Omar Fernando, Lau, Anna F., Lázár-Molnár, Eszter, Liesman, Rachael M., Linnet, Kristian, Lo, Stanley F., Lo, Yuk Ming Dennis, Longo, Nicola, Lyon, Elaine, Ma, Edmond S.K., Mackay, Mark, Madkaikar, Manisha, Manis, John P., Mardis, Elaine R., Master, Stephen R., Mathison, Blaine A., McElvania, Erin, McMillin, Gwendolyn Appell, Meeusen, Jeffrey W., Michniacki, Thomas F., Miller, Melissa B., Miller, W. Greg, Milone, Michael C., Mochon, Brian, Moons, Karel G.M., Mostafa, Heba H., Nerenz, Robert D., Nordestgaard, Børge G., Nygaard, Birte, O’Kane, Maurice, Pagano, Monica B., Pamidi, Prasad V.A., Panteghini, Mauro, Pantel, Klaus, Park, Jason Y., Pasquali, Marzia, Patel, Jay L., Patel, Khushbu, Patel, Robin, Peake, Roy W.A., Pence, Morgan A., Perrotta, Peter L., Pillay, Tahir S., Poston, Jacqueline N., Pratt, Victoria M., Pritt, Bobbi S., Procop, Gary W., Rab, Minke A.E., Rao, Lokinendi V., Rappold, Brian A., Rashidi, Hooman H., Remaley, Alan T., Rifai, Nader, Rockwood, Alan L., Røraas, Thomas, Rosenberg, William Malcolm Charles, Sacks, David B., Sandberg, Sverre, Schifman, Ronald, Schmitt, Caroline, Sethi, Amar Akhtar, Shapiro, Howard M., Shaw, Leslie Michael, Sherwood, Roy Alan, Simundic, Ana-Maria, Snyder, Melissa R., So, Jason C.C., Sodi, Ravinder, Strathmann, Frederick G., Sturgeon, Catharine, Swinkels, Dorine W., Taly, Valérie, Tanwar, Sudeep, Tebo, Anne E., TeKippe, Michael, Thatcher, Stephanie A., Tran, Nam K., Tsongalis, Gregory J., Ueda, Masako, van Wijk, Richard, Vaught, Jim B., Vnencak-Jones, Cindy L., Wadelius, Mia, Walkovich, Kelly, Walsham, Natalie E., Wang, Ping, Wells, David A., Wengenack, Nancy L., Whatley, Sharon D., Willrich, Maria Alice Vieira, Winter, William E., Wittwer, Carl T., Wood, Timothy, Yoon, Edward J., Young, Ian, Zhang, Qian-Yun, and Zimmermann, Stefan

Published
2023
Full Text
View/download PDF

41. Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions

Author

Zheng, Yue, primary, Larragoite, Erin T., additional, Lama, Juan, additional, Cisneros, Isabel, additional, Delgado, Julio C., additional, Slev, Patricia, additional, Rychert, Jenna, additional, Innis, Emily A., additional, Williams, Elizabeth S.C.P., additional, Coiras, Mayte, additional, Rondina, Matthew T., additional, Spivak, Adam M., additional, and Planelles, Vicente, additional

Published
2020
Full Text
View/download PDF

43. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresis

Author

Turner, Katherine A., primary, Frinack, Jody L., additional, Ettore, Michael W., additional, Tate, Jillian R., additional, Graziani, Maria Stella, additional, Jacobs, Joannes F.M., additional, Booth, Ronald A., additional, McCudden, Christopher R., additional, Keren, David F., additional, Delgado, Julio C., additional, Zemtsovskaja, Galina, additional, Fullinfaw, Robert O., additional, Caldini, Anna, additional, de Malmanche, Theo, additional, Katakouzinos, Katina, additional, Burke, Matthew, additional, Palladini, Giovanni, additional, Altinier, Sara, additional, Zaninotto, Martina, additional, Righetti, Gabriella, additional, Melki, Marie Therese, additional, Bell, Stephen, additional, and Willrich, Maria Alice Vieira, additional

Published
2020
Full Text
View/download PDF

44. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteins

Author

Jacobs, Joannes F.M., primary, Turner, Katherine A., additional, Graziani, Maria Stella, additional, Frinack, Jody L., additional, Ettore, Michael W., additional, Tate, Jillian R., additional, Booth, Ronald A., additional, McCudden, Christopher R., additional, Keren, David F., additional, Delgado, Julio C., additional, Zemtsovskaja, Galina, additional, Fullinfaw, Robert O., additional, Caldini, Anna, additional, de Malmanche, Theo, additional, Katakouzinos, Katina, additional, Burke, Matthew, additional, Palladini, Giovanni, additional, Altinier, Sara, additional, Zaninotto, Martina, additional, Righetti, Gabriella, additional, Melki, Marie Therese, additional, Bell, Stephen, additional, and Willrich, Maria Alice Vieira, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results